Literature DB >> 31782055

An unusual cause of intestinal obstruction: phlebosclerotic colitis.

Yu-Chang Liu1, Wei-Jing Lee2.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31782055     DOI: 10.1007/s11739-019-02241-x

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  5 in total

1.  Phlebosclerotic colitis with nonsurgical treatment.

Authors:  Cheng-Ju Yu; Hwang-Huei Wang; Jen-Wei Chou; Hsueh-Chou Lai; Wen-Hsin Huang; Cheng-Yuan Peng; Ken-Sheng Cheng; Yung-Fang Chen
Journal:  Int J Colorectal Dis       Date:  2009-04-24       Impact factor: 2.571

2.  Perforated phlebosclerotic colitis--description of a case and review of this condition.

Authors:  T Kato; K Miyazaki; T Nakamura; K Y Tan; T Chiba; F Konishi
Journal:  Colorectal Dis       Date:  2008-10-25       Impact factor: 3.788

3.  Phlebosclerotic colitis: value of radiography in diagnosis--report of three cases.

Authors:  T Yao; A Iwashita; T Hoashi; T Matsui; T Sakurai; S Arima; H Ono; R J Schlemper
Journal:  Radiology       Date:  2000-01       Impact factor: 11.105

4.  Phlebosclerotic colitis: imaging-pathologic correlation.

Authors:  Miho Kusanagi; Osamu Matsui; Hiroko Kawashima; Toshifumi Gabata; Masahiro Ida; Hitoshi Abo; Kumiko Isse
Journal:  AJR Am J Roentgenol       Date:  2005-08       Impact factor: 3.959

5.  New histologic findings in idiopathic mesenteric phlebosclerosis: clues to its pathogenesis and etiology--probably ingested toxic agent-related.

Authors:  Kuo-Ming Chang
Journal:  J Chin Med Assoc       Date:  2007-06       Impact factor: 2.743

  5 in total
  1 in total

1.  Performance of qSOFA, SIRS, and the qSOFA + SIRS combinations for predicting 30-day adverse outcomes in patients with suspected infection.

Authors:  Olcay Yeşil; Murat Pekdemir; İbrahim Ulaş Özturan; Nurettin Özgür Doğan; Elif Yaka; Serkan Yılmaz; Adnan Karadaş; Seda Güney Pınar
Journal:  Med Klin Intensivmed Notfmed       Date:  2021-09-29       Impact factor: 0.840

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.